Brief Reports
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 295-298
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.295
Table 1 Improvement of symptoms and signs in both groups before and after treatment
Symptoms and signsTreated group
Control group
χ2P
BTATDR(%)BTATAT
Fatigue291451.7126500.10> 0.05
Abdominal distension3197113561.50.375> 0.05
Nausea12741.786250.586> 0.05
Anorexia23673.911463.60.379> 0.05
Hepatic pain171041.27528.60.336> 0.05
Sallow complexion14471.453401.564> 0.05
Hepatomegaly20124063500.189> 0.05
Splenomegaly9722.243250.012> 0.05
Percussion pain of liver211242.99544.40.006> 0.05